V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10466199 | 10035374 | 1.76 | 80 | Palliative (P) | 2018-05-25 | 2018-06-16 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100396658 |
| 10466206 | 10035375 | 1.54 | 64 | 03 | 2019-03-27 | 2019-04-05 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100428373 |
| 10466211 | 10035376 | 0 | 78 | null | null | 2020-10-09 | null | null | null | RUXOLITINIB | 100119674 |
| 10466238 | 10035377 | 1.63 | 0 | Palliative (P) | 2016-05-28 | 2016-06-02 | CARBOPLATIN + ETOPOSIDE | N | N | CARBOPLATIN + ETOPOSIDE | 100760717 |
| 10466239 | 10035378 | 1.78 | 80 | 03 | 2018-05-24 | 2018-05-24 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100696185 |
| 10466251 | 10035379 | 1.69 | 61.4 | 03 | null | 2018-10-17 | null | 02 | N | ABIRATERONE | 100142552 |
| 10466254 | 10035380 | 1.54 | null | Disease modification (D) | null | 2021-07-05 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101691384 |
| 10466271 | 10035381 | 1.76 | 103.7 | Palliative (P) | 2017-11-16 | 2017-11-27 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101587354 |
| 10466289 | 10035382 | 0 | 76 | Curative (C) | null | 2020-09-03 | null | 02 | null | ABIRATERONE | 100415725 |
| 10466291 | 10035383 | 1.65 | 66.5 | Disease modification (D) | null | 2016-10-31 | null | 02 | N | CARBOPLATIN | 101261488 |
| 10466302 | 10035384 | null | null | Palliative (P) | 2019-09-21 | 2019-09-22 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100890849 |
| 10466303 | 10035385 | 1.89 | 57.5 | Curative (C) | 2022-01-27 | 2022-02-05 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100100936 |
| 10466310 | 10035386 | 1.75 | 52.1 | Curative (C) | 2021-12-26 | 2022-01-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101684888 |
| 10466316 | 10035387 | 0 | 97.8 | null | 2018-08-31 | 2018-09-15 | Abiraterone | 02 | null | CEMIPLIMAB | 101797197 |
| 10466340 | 10035388 | 0 | 0 | Palliative (P) | 2016-07-29 | 2016-08-12 | Abiraterone | 02 | N | ABIRATERONE | 101257852 |
| 10466346 | 10035389 | 1.79 | 0 | Neo-adjuvant (N) | null | 2019-12-13 | null | 02 | N | BENDAMUSTINE + RITUXIMAB | 101420837 |
| 10466357 | 10035390 | 1.74 | 63.7 | null | null | 2017-06-20 | null | null | null | BENDAMUSTINE + RITUXIMAB | 100885677 |
| 10466364 | 10035391 | 1.73 | 69 | null | 2018-04-14 | 2018-05-10 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100619852 |
| 10466374 | 10035393 | 0 | 93.4 | Palliative (P) | 2018-12-19 | 2019-02-06 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100282548 |
| 10466393 | 10035394 | 1.67 | 64.2 | null | null | 2019-11-23 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100578691 |
| 10466397 | 10035395 | 1.76 | 62.7 | null | null | 2018-12-28 | null | 02 | null | LENALIDOMIDE | 100460781 |
| 10466402 | 10035396 | 0 | 0 | Palliative (P) | null | 2020-07-22 | null | 2 | Y | CEMIPLIMAB | 100259812 |
| 10466403 | 10035397 | 1.76 | 66 | Disease modification (D) | null | 2020-10-31 | null | Y | N | CARBOPLATIN + PACLITAXEL | 101297916 |
| 10466435 | 10035398 | 0 | 94.8 | Adjuvant (A) | 2017-01-26 | 2017-07-12 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100525900 |
| 10466464 | 10035399 | 1.67 | 61 | null | 2021-08-26 | 2021-09-09 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100760008 |
| 10466474 | 10035400 | 1.62 | 43.2 | Palliative (P) | null | 2017-03-26 | null | 02 | N | ABIRATERONE | 101577787 |
| 10466476 | 10035401 | 1.63 | null | Curative (C) | null | 2017-06-08 | Bendamustine+Rituximab (1st Course) | 02 | null | BENDAMUSTINE + RITUXIMAB | 100496820 |
| 10466489 | 10035402 | 1.65 | 68.6 | Palliative (P) | 2018-03-31 | 2018-03-31 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 101364634 |
| 10466502 | 10035404 | null | 77.2 | 03 | null | 2015-06-11 | null | 02 | N | LENALIDOMIDE | 101255781 |
| 10466512 | 10035405 | 1.7 | 70 | Palliative (P) | 2014-07-23 | 2014-07-31 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | LENALIDOMIDE | 100153977 |
| 10466514 | 10035406 | 1.65 | 84.3 | 03 | 2018-05-05 | 2018-05-05 | Lenalidomide Cycle 26 onwards (PAS) | 02 | N | LENALIDOMIDE | 101022949 |
| 10466517 | 10035407 | 1.56 | 85 | Neo-adjuvant (N) | null | 2019-03-20 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100766815 |
| 10466518 | 10035408 | 1.62 | 69 | Disease modification (D) | 2021-01-15 | 2021-01-28 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101553310 |
| 10466538 | 10035409 | 1.56 | 45.8 | null | 2019-03-31 | 2019-04-01 | Carboplatin + Etoposide iv&po | null | null | CARBOPLATIN + ETOPOSIDE | 101761628 |
| 10466542 | 10035410 | 1.62 | 65.18 | Disease modification (D) | null | 2017-10-29 | null | N | N | BENDAMUSTINE + RITUXIMAB | 100671338 |
| 10466556 | 10035411 | 1.78 | 67.3 | null | null | 2016-05-22 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100648721 |
| 10466559 | 10035412 | 1.63 | 82.9 | null | 2018-02-08 | 2018-02-14 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 101354250 |
| 10466592 | 10035413 | 1.85 | 59.7 | Adjuvant (A) | 2021-01-28 | 2021-02-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100554071 |
| 10466618 | 10035414 | null | 102.6 | Curative (C) | null | 2018-08-02 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 101109428 |
| 10466619 | 10035415 | 1.76 | 54.6 | Palliative (P) | 2020-05-07 | 2020-05-24 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100931924 |
| 10466645 | 10035416 | 1.73 | 95.8 | Palliative (P) | 2015-08-02 | 2015-08-29 | Carboplatin + Paclitaxel (weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100970607 |
| 10466671 | 10035417 | 1.86 | 79.6 | Palliative (P) | null | 2016-09-08 | null | N | N | LENALIDOMIDE | 100006676 |
| 10466675 | 10035418 | 1.71 | 77.6 | Palliative (P) | 2019-12-10 | 2019-12-17 | Bendamustine+Rituximab (1st Course) | 02 | N | BENDAMUSTINE + RITUXIMAB | 100865504 |
| 10466686 | 10035419 | 0 | 0 | Neo-adjuvant (N) | 2016-06-15 | 2016-07-26 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101270499 |
| 10466707 | 10035420 | 0 | 68.2 | 03 | 2014-08-03 | 2014-08-03 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101079933 |
| 10466709 | 10035421 | 1.67 | 86.5 | Adjuvant (A) | null | 2018-10-22 | null | null | N | BENDAMUSTINE + RITUXIMAB | 101058465 |
| 10466725 | 10035422 | null | null | Palliative (P) | 2020-04-25 | 2020-05-11 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101833251 |
| 10466749 | 10035423 | 1.85 | 91.4 | null | null | 2018-09-29 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100534313 |
| 10466767 | 10035424 | 0 | 0 | Disease modification (D) | 2017-02-04 | 2017-02-04 | RUXOLITINIB | N | N | RUXOLITINIB | 101582196 |
| 10466776 | 10035425 | 1.69 | 57.9 | null | 2019-01-15 | 2019-02-19 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101406274 |